These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2815274)

  • 21. Permanent rat cardiac allograft survival induced by ultraviolet B-irradiated donor lymphocytes and peritransplant cyclosporine.
    Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA
    Surgery; 1988 Aug; 104(2):231-8. PubMed ID: 2969630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
    Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
    J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of antigen-presenting cells in the survival of murine-cultured keratinocyte allografts.
    Yeoman H; Ramrakha PS; Sharp RJ; Stanley MA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):263. PubMed ID: 2468216
    [No Abstract]   [Full Text] [Related]  

  • 24. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?
    Hargrave SL; Mayhew E; Hegde S; Niederkorn J
    Transpl Immunol; 2003; 11(1):79-89. PubMed ID: 12727479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
    Yamada J; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression.
    Beutelspacher SC; Pillai R; Watson MP; Tan PH; Tsang J; McClure MO; George AJ; Larkin DF
    Eur J Immunol; 2006 Mar; 36(3):690-700. PubMed ID: 16482510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depletion of donor-derived Langerhans cells promotes corneal allograft survival.
    He YG; Niederkorn JY
    Cornea; 1996 Jan; 15(1):82-9. PubMed ID: 8907386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor-specific antigen transfusion-mediated skin-graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells.
    Margenthaler JA; Kataoka M; Flye MW
    Transplantation; 2003 Jun; 75(12):2119-27. PubMed ID: 12829922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New possibilities for reducing transplant immunogenicity by influencing the antigen-presenting cells--results of basic immunologic research].
    Gruner S; Oesterwitz H; Scholz D; Volk HD; Meffert H; von Baehr R
    Z Exp Chir Transplant Kunstliche Organe; 1986; 19(6):349-51. PubMed ID: 3548111
    [No Abstract]   [Full Text] [Related]  

  • 30. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress.
    Katiyar SK; Mukhtar H
    J Leukoc Biol; 2001 May; 69(5):719-26. PubMed ID: 11358979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thy 1+ donor cells function as veto cells in the maintenance of tolerance across a major histocompatibility complex disparity in mixed-lymphoid radiation chimeras.
    Pierce GE; Watts LM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):331-3. PubMed ID: 8438323
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of Fas ligand as an effector molecule in corneal graft rejection.
    Stuart PM; Yin X; Plambeck S; Pan F; Ferguson TA
    Eur J Immunol; 2005 Sep; 35(9):2591-7. PubMed ID: 16114107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viable antigen-presenting cells are required for induction of intrathymic tolerance.
    Nakafusa Y; Goss JA; Flye MW
    Transplant Proc; 1994 Apr; 26(2):845-6. PubMed ID: 8171684
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of allergic conjunctival inflammation on the allogeneic response to donor cornea.
    Flynn TH; Ohbayashi M; Ikeda Y; Ono SJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4044-9. PubMed ID: 17724186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prolongation of graft survival--clinical practice, specific immune suppression in experiments and photochemotherapy of the graft].
    Meffert H; Gruner S; Sönnichsen N; von Baehr R
    Dermatol Monatsschr; 1985; 171(5):290-302. PubMed ID: 3894077
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of ultraviolet radiation treatment on the survival of heterotopic skin grafts in the mouse.
    Claas FH; Rothert M; Havinga I; Schothorst AA; Vermeer BJ; van Rood JJ
    J Invest Dermatol; 1985 Jan; 84(1):31-2. PubMed ID: 3880794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cells infiltrating inflamed and vascularized corneas.
    Williams KA; Ash JK; Mann TS; Noonan FP; Coster DJ
    Transplant Proc; 1987 Apr; 19(2):2889-91. PubMed ID: 3551231
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches.
    Duguid IG; Koulmanda M; Mandel TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):844. PubMed ID: 8438499
    [No Abstract]   [Full Text] [Related]  

  • 39. Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes.
    Shreedhar VK; Pride MW; Sun Y; Kripke ML; Strickland FM
    J Immunol; 1998 Aug; 161(3):1327-35. PubMed ID: 9686595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
    Sonoda A; Sonoda Y; Muramatu R; Streilein JW; Usui M
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):790-8. PubMed ID: 10711695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.